INTERNATIONAL PATENT: ACONCAGUA BIO, INC. FILES APPLICATION FOR "THE TREATMENT OF CALCITONIN- AND/OR AMYLIN-RECEPTOR ASSOCIATED CONDITIONS"

GENEVA, Aug. 19 -- ACONCAGUA BIO, INC. (601 Gateway Blvd., Suite 900South San Francisco, California 94080) filed a patent application (PCT/US2025/015122) for "THE TREATMENT OF CALCITONIN- AND/OR AMYLIN-RECEPTOR ASSOCIATED CONDITIONS" on Feb 07, 2025. With publication no. WO/2025/171340, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEI, Hui (c/o Aconcagua Bio, Inc.601 Gateway Blvd., Suite 900South San Francisco, California 94080), LI, Cui (c/o Aconcagua Bio, Inc.601 Gateway Blvd., Suite 900South San Francisco, Californi...